ARICÒ, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.886
AS - Asia 633
EU - Europa 485
SA - Sud America 118
AF - Africa 106
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.237
Nazione #
US - Stati Uniti d'America 1.828
SG - Singapore 227
CN - Cina 173
HK - Hong Kong 92
BR - Brasile 88
IT - Italia 88
SE - Svezia 84
FI - Finlandia 48
PL - Polonia 36
DE - Germania 34
FR - Francia 25
IE - Irlanda 24
GB - Regno Unito 17
RU - Federazione Russa 17
GR - Grecia 15
VN - Vietnam 15
UA - Ucraina 11
CA - Canada 9
MX - Messico 9
ES - Italia 8
IN - India 8
IQ - Iraq 8
JP - Giappone 8
TR - Turchia 8
KR - Corea 7
NL - Olanda 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
EE - Estonia 6
LC - Santa Lucia 6
MZ - Mozambico 6
PE - Perù 6
PT - Portogallo 6
BY - Bielorussia 5
EC - Ecuador 5
GT - Guatemala 5
IL - Israele 5
IR - Iran 5
KE - Kenya 5
MG - Madagascar 5
MK - Macedonia 5
MR - Mauritania 5
MU - Mauritius 5
NI - Nicaragua 5
RO - Romania 5
SO - Somalia 5
AD - Andorra 4
AF - Afghanistan, Repubblica islamica di 4
AO - Angola 4
AT - Austria 4
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
CV - Capo Verde 4
DJ - Gibuti 4
HR - Croazia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PS - Palestinian Territory 4
PY - Paraguay 4
TL - Timor Orientale 4
TN - Tunisia 4
TW - Taiwan 4
ZW - Zimbabwe 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
CL - Cile 3
CM - Camerun 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GF - Guiana Francese 3
GH - Ghana 3
GN - Guinea 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
LY - Libia 3
MD - Moldavia 3
MN - Mongolia 3
NA - Namibia 3
NE - Niger 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
YT - Mayotte 3
ZA - Sudafrica 3
ZM - Zambia 3
AL - Albania 2
BD - Bangladesh 2
BG - Bulgaria 2
BJ - Benin 2
CD - Congo 2
CG - Congo 2
CR - Costa Rica 2
Totale 3.178
Città #
Fairfield 227
Houston 172
Singapore 156
Ann Arbor 152
Ashburn 152
Woodbridge 150
Chandler 120
Hong Kong 92
Cambridge 88
Seattle 85
Santa Clara 82
Wilmington 77
Boardman 52
Beijing 48
Des Moines 30
Padova 30
Princeton 30
Medford 28
Roxbury 28
Jacksonville 26
Dublin 23
Guangzhou 23
Bytom 22
Nanjing 21
San Diego 21
Helsinki 17
Los Angeles 17
Cagliari 12
Buffalo 9
Council Bluffs 8
New York 7
Abidjan 6
Castries 6
Hefei 6
Maputo 6
Munich 6
Nanchang 6
Redondo Beach 6
Antananarivo 5
Hanoi 5
Ho Chi Minh City 5
Managua 5
Milan 5
Nouakchott 5
Quito 5
Shenyang 5
Tallinn 5
Tokyo 5
Warsaw 5
Andorra la Vella 4
Baku 4
Chicago 4
Dili 4
Djibouti 4
Hebei 4
Jiaxing 4
Lima 4
Luanda 4
Minsk 4
Nairobi 4
Norwalk 4
Praia 4
San Francisco 4
Skopje 4
São Paulo 4
Tappahannock 4
Vientiane 4
Zagreb 4
Accra 3
Amman 3
Ankara 3
Changsha 3
Chisinau 3
Conakry 3
Guatemala City 3
Harare 3
Hargeisa 3
Jeddah 3
Kabul 3
London 3
Lusaka 3
Naples 3
Niamey 3
Ogden 3
Porto 3
Riga 3
Rio de Janeiro 3
San Jose 3
Shenzhen 3
Stockholm 3
Tianjin 3
Tripoli 3
Tunis 3
Ulan Bator 3
Al Ain City 2
Aracaju 2
Astana 2
Athens 2
Baghdad 2
Basra 2
Totale 2.268
Nome #
Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma. 171
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma 170
Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation 167
Matrix metalloproteinases and their inhibitors in canine mammary tumors 147
Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target? 142
Platelet-derived Growth Factors and Receptors in Canine Lymphoma. 140
Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Vascular Endothelial Growth Factor in Canine Mast Cell Tumours. 139
CD44 in canine leukemia: Analysis of mRNA and protein expression in peripheral blood 138
Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma 135
Interaction between tumour and microenvironment - molecular mechanisms of cell migration in canine tumours 135
Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias 129
VEGF and MMP-9: biomarkers for canine lymphoma 127
Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: Might c-kit represent a therapeutic target? 125
The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study 119
X-Linked Hereditary Nephropathy in Navasota Dogs: Clinical Pathology, Morphology, and Gene Expression During Disease Progression 110
Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma. 109
Evaluation of c-KIT (CD117) mutations, mRNA and protein expression in canine leukemia and lymphoma: might c-KIT represent a therapeutical target? 102
Minimal Residual Disease assessment based on IgH rearrangements and flow cytometry in canine Diffuse Large B-cell Lymphoma 97
INTERACTION BETWEEN TUMOUR AND MICROENVIRONMENT - MOLECULAR MECHANISMS OF CELL MIGRATION IN CANINE TUMOURS 96
Molecole di adesione e metalloproteasi: indagine sul ruolo di CD44 e MMP-9 nelle neoplasie ematopoietiche canine 94
Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large b-cell lymphoma 91
Matrix methalloproteinases and vascular endothelial growth factor in canine lymphohematopoietic malignancies 84
The role of growth factors in canine X-linked hereditary nephropathy: an animal model of progressive renal failure. 82
Expression of matrix metalloproteinases, metalloproteinase inhibitors and vascular endothelial growth factor in canine mast cell tumours: preliminary results 78
Clinical spectrum of canine lymphoma with histologic correlation according to the Who classification- recognizing differences. 74
Genetic heterogeneity of canine DLBCL by Oligonucleotide Array CGH. 69
Espressione dell' hmw-maa nei melanomi orali canini come potenziale target terapeutico in immunoterapia. 63
Genetic heterogeneity of canine DLBCL by Oligonucleotide Array CGH. 63
VEGF e MMP-9 cross-talk: possibili biomarcatori nel linfoma canino. 53
Totale 3.249
Categoria #
all - tutte 10.820
article - articoli 7.373
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 12 10 6 32 4 17 56 18 36 24
2021/2022363 23 67 27 9 10 40 25 21 18 10 27 86
2022/2023301 50 7 1 38 65 62 4 18 36 3 13 4
2023/2024157 3 30 29 14 2 14 1 13 4 15 14 18
2024/2025716 1 76 38 35 118 22 30 42 46 25 128 155
2025/2026580 168 175 237 0 0 0 0 0 0 0 0 0
Totale 3.249